3 completed, 1 unknown. 2 Phase 3, 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
| Phase 4 | 1 | Unknown 1 |
Follow West-Ward Pharmaceutical: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Endpoint Bioequivalence Study of Fluticasone Propionate & Salmeterol Xinafoate (100μg/50μg) Fluticasone propionate/salmeterol, Advair Diskus, 100 Mcg-50 Mcg Inhalation Powder, Placebo - Asthma | Not applicable | Completed | West-Ward Pharmaceutical | 1556 | 2018-04-26 | 2019-11-29 |
| Study of Oral Morphine Sulfate Administration in Pediatric Subjects Morphine Sulfate - Pain, Postoperative | Phase 3 | Completed | West-Ward Pharmaceutical | 51 | 2018-04-17 | 2019-09-26 |
| Study to Determine the Pharmacokinetics and Pharmacodynamic Effects of Phenylephrine on BP Via IV Phenylephrine - Hypotension | Phase 4 | Unknown | West-Ward Pharmaceutical | 100 | 2015-02-01 | 2024-07-23 |
| Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures Phenobarbital, Placebo tablet - Epilepsy | Phase 3 | Completed | West-Ward Pharmaceutical | 314 | 2010-11-01 | 2017-11-14 |
Asthma (1) · Epilepsy (1) · Hypotension (1) · Pain, Postoperative (1)
Fluticasone-Salmeterol Drug Combination (1) · Morphine (1) · Phenobarbital (1) · Phenylephrine (1)
United States (4) · Puerto Rico (1)
Cesar Ormeno, MD (1) · Susanne Schmidt, MD,PhD (1)